Skip to main content
Watch Insiders

Institutional filer profile

OrbiMed Capital GP VIII LLC Insider Trades

Latest reported as Corporate insider of BlossomHill Therapeutics, Inc. (BLSM).

Purchase filings
3
Reported companies
4
Net open-market value
-$21,912,912.19
Latest transaction
Aug 10, 2026

Affiliated corporations

Reported company relationships

BLSMLatest reported

BlossomHill Therapeutics, Inc.

Corporate insider

SCTXPrior filing

Scribe Therapeutics, Inc.

Corporate insider

SIONPrior filing

Sionna Therapeutics, Inc.

Corporate insider

TRAWPrior filing

Traws Pharma, Inc.

Corporate insider

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 10, 2026BlossomHill Therapeutics, Inc. (BLSM)Corporate insiderOpen Market Purchase625,000$16.00$10,000,000
Jul 27, 2026Scribe Therapeutics, Inc. (SCTX)Corporate insiderOpen Market Purchase1,000,000$15.00$15,000,000
Jul 7, 2026Sionna Therapeutics, Inc. (SION)Corporate insiderSale85,918$44.86$3,854,281
Jun 30, 2026Sionna Therapeutics, Inc. (SION)Corporate insiderSale115,844$45.50$5,270,902
May 27, 2026Sionna Therapeutics, Inc. (SION)Corporate insiderSale101$44.49$4,493
May 11, 2026Sionna Therapeutics, Inc. (SION)Corporate insiderSale292,952$45.62$13,364,060
Apr 18, 2026Sionna Therapeutics, Inc. (SION)Corporate insiderSale55,345$44.67$2,472,344
Apr 16, 2026Traws Pharma, Inc. (TRAW)Corporate insiderOpen Market Purchase597,729$1.67$998,207
Apr 16, 2026Sionna Therapeutics, Inc. (SION)Corporate insiderSale510,583$44.94$22,945,038